Redhill Biopharma
RDHL
#11160
Rank
S$3.22 M
Marketcap
S$0.36
Share price
-13.08%
Change (1 day)
-73.34%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2022: -S$92.46 Million

According to Redhill Biopharma's latest financial reports the company's current earnings are S$35.74 Million. In 2022 the company made an earning of -S$92.46 Million, an increase over its 2021 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2022

Annual earnings

Year Earnings Change
2022-S$92.46 Million-26.68%
2021-S$0.13 Billion28.32%
2020-S$98.27 Million80.06%
2019-S$54.58 Million8.97%
2018-S$50.08 Million-14.76%
2017-S$58.76 Million55.07%
2016-S$37.89 Million39.26%
2015-S$27.21 Million96.9%
2014-S$13.82 Million0.78%
2013-S$13.72 Million16.93%
2012-S$11.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$10.04 B 67,200.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$8.67 B 57,997.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.22 B 61,725.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.57 B 10,477.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
S$56.4 M 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel